Clinical Trial Update: Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk [Phase 2]

View source ↗

Summary

Phase 2 trial comparing oral tamoxifen, TamGel (topical tamoxifen), and control in women at increased risk for breast cancer or with atypical breast changes was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hyperplasia of the Breast
• Atypical Lobular Hyperplasia
• Breast Cancer
• Lobular Carcinoma in Situ

Drugs mentioned

• TamGel (tamoxifen gel)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Atypical Hyperplasia, Breast Lobular Carcinoma in Situ | Phase 2 | Status: TERMINATED